The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies.
Cortés, Javier
The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies. [electronic resource] - Cancer treatment reviews Dec 2017 - 53-60 p. digital
Publication Type: Journal Article; Review
1532-1967
10.1016/j.ctrv.2017.09.011 doi
Animals
Breast Neoplasms--drug therapy
Cyclin-Dependent Kinase 4--antagonists & inhibitors
Cyclin-Dependent Kinase 6--antagonists & inhibitors
Female
Humans
Phosphoinositide-3 Kinase Inhibitors
Protein Kinase Inhibitors--therapeutic use
Receptor, ErbB-2--metabolism
Receptors, Estrogen--metabolism
TOR Serine-Threonine Kinases--antagonists & inhibitors
The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies. [electronic resource] - Cancer treatment reviews Dec 2017 - 53-60 p. digital
Publication Type: Journal Article; Review
1532-1967
10.1016/j.ctrv.2017.09.011 doi
Animals
Breast Neoplasms--drug therapy
Cyclin-Dependent Kinase 4--antagonists & inhibitors
Cyclin-Dependent Kinase 6--antagonists & inhibitors
Female
Humans
Phosphoinositide-3 Kinase Inhibitors
Protein Kinase Inhibitors--therapeutic use
Receptor, ErbB-2--metabolism
Receptors, Estrogen--metabolism
TOR Serine-Threonine Kinases--antagonists & inhibitors